What is ABBV's current stock price?

As of now, ABBV is trading at $229.57, with a daily change of +1.19%.

What are the risks associated with ABBV stock?

ABBV Key risk is its Low Risk Level, .

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ABBV Stock Analysis & IQ Rating | AbbVie

ABBV

AbbVie

$229.57

+$2.70 | +1.19%

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 244.81

MKT CAP

$ 404.21B

52W Low

$ 163.81

VOL

$ 2.79M

P/E Ratio

109.25

AVG VOL

$ 6.17M

RSI

57.02

TREND

Uptrend

ABBV Stock IQ

Login to see AbbVie (ABBV) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABBV Target Price

Login to display

Strengths

ABBV Rewards

Earnings are forecast to grow

ABBV Rewards

Trading below its fair value

ABBV Rewards

Investors confidence is positive

ABBV Rewards

Pays a reliable dividend

Chart

$222.61 (+3.13%)

$188.52 (+21.77%)

$185.62 (+23.68%)

$203.55 (+12.78%)

1year

6month

3month

1month

ABBV Risk Level

ABBV has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

LOW

HIGH

ABBV Analysts Opinion

ABBV overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ABBV Analysts Opinion

ABBV Analysts opinion is positive but there was a setback from the past 3 months

ABBV Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

85%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

25%

89%

ABBV Street Opinion

ABBV Street view is extremely bullish and have positive views on the near-term outlook

ABBV Performance Sentiment

Sentiments overview associated with ABBV events and the stock performance.

85%

10%

Positive

Negative

44 out of 52
events present

5 out of 52
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$229.57

Resistance
Price

$214.05

Current Price Range

$244.38

Show methods +

Linked to ABBV

IQ

Close Price

Change

PFE

4.15

24.51

+1.18%

NVS

4.26

131.43

+0.50%

LLY

4.18

802.83

-2.02%

SNY

3.94

50.62

+1.19%

TEVA

2.52

19.31

-1.63%

ABBV Latest Analysis +

AbbVie: Strong Buy On Rinvoq Expansions And Immunology Pipeline Addition.

Fri Oct 17, 2025

$229.57 | +1.19%

Rating

AbbVie finishes acquisition of depression asset bretisilocin from Gilgamesh.

Fri Oct 17, 2025

$229.57 | +1.19%

Activity

Cantor Fitzgerald Reaffirms Overweight Rating on AbbVie (ABBV). AbbVie Inc. (NYSE:ABBV) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. A global pharmaceutical company AbbVie Inc. (NYSE:ABBV) is among the best dividend stocks in the healthcare sector. On October 14 C‍antor Fitzgerald reaffirmed⁠ its Overwe⁠ight rating a⁠nd $2‍5⁠0 price targ⁠et‌ f‍or AbbVie Inc. (NYSE:ABBV) while revising its earnings model⁠ to [….]

Thu Oct 16, 2025

$226.87 | +0.21%

Rating

AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know. The latest trading day saw AbbVie (ABBV) settling at $226.22 representing a -1.27% change from its previous close.

Wed Oct 15, 2025

$226.22 | -0.56%

Momentum

Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie?. ABBV leans on booming Skyrizi and Rinvoq-driven sales to sustain growth and counter Humiras decline as Q3 results approach.

Tue Oct 14, 2025

$229.13 | -0.51%

Earnings

AbbVie Gets FDA Approval To Expand RINVOQ Use For Ulcerative Colitis And Crohns Disease . (RTTNews) - AbbVie (ABBV) Monday announced the United States Food and Drug Administration (FDA) approval of a supplemental new drug application (sNDA) that updates the indication statement for RINVOQ (upadacitinib) for the treatment of adults with moderately to severely active ulcerative

Mon Oct 13, 2025

$230.30 | -0.13%

Activity

Ex-Dividend Reminder: Abbott Laboratories AbbVie and ARMOUR Residential REIT . Looking at the universe of stocks we cover at Dividend Channel on 10/15/25 Abbott Laboratories (Symbol: ABT) AbbVie Inc (Symbol: ABBV) and ARMOUR Residential REIT Inc. (Symbol: ARR) will all trade ex-dividend for their respective upcoming dividends. Abbott Laboratories will

Mon Oct 13, 2025

$230.30 | -0.13%

Activity

AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors. New data from telisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic colorectal and solid tumors highlight progress in AbbVies growing ADC portfolio designed to target difficult-to-treat cancers. NORTH CHICAGO Ill. Oct. 13 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today...

Mon Oct 13, 2025

$230.30 | -0.13%

Activity

Carolina Wealth Trims Its AbbVie Stake to Nearly Nothing. Key PointsCarolina Wealth Advisors sold 38267 AbbVie shares. estimated transaction value ~$7.79 million based on quarterly average price

Thu Oct 9, 2025

$230.69 | -0.24%

Activity

Cantor Fitzgerald raises Abbvie stock price target to $250 on strong Skyrizi performance.

Thu Oct 9, 2025

$230.69 | -0.24%

Earnings

Potential

FAQ About ABBV Stock Insights

What is ABBV current stock price?

What are ABBV stock strengths?

What risks are associated with ABBV stock?

When is ABBV next earnings report?

What is ABBV market cap and volume?

What is ABBV's current Stock IQ?

Should I buy ABBV stock right now?

Is ABBV a Strong Buy right now?

What does a 'Strong Buy' rating mean for ABBV?

What does a 'Strong Sell' rating mean for ABBV?

What factors influence ABBV's Stock IQ?

Explore our ABBV Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ABBV Stock Strategies
Effective Risk Management

FIND US ON

Receive our ABBV Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ABBV

AbbVie

Current Price

$229.57

+$2.70 | +1.19%

52W High

$ 244.81

MKT CAP

$ 404.21B

52W Low

$ 163.81

VOL

$ 2.79M

P/E Ratio

109.25

AVG VOL

$ 6.17M

RSI

57.02

TREND

Uptrend

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

ABBV Rewards

Earnings are forecast to grow

ABBV Rewards

Trading below its fair value

ABBV Rewards

Investors confidence is positive

ABBV Rewards

Pays a reliable dividend

Linked to ABBV

Symbol

IQ

Close

Change

PFE

4.15

24.51

+1.18%

NVS

4.26

131.43

+0.50%

LLY

4.18

802.83

-2.02%

SNY

3.94

50.62

+1.19%

TEVA

2.52

19.31

-1.63%

ABBV Stock IQ

Login to unlock AbbVie (ABBV) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$222.61 (+3.13%)

$188.52 (+21.77%)

$185.62 (+23.68%)

$203.55 (+12.78%)

1year

6month

3month

1month

ABBV Analysts Opinion

ABBV Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

ABBV Analysts Opinion

ABBV Analysts opinion is positive but there was a setback from the past 3 months

ABBV Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

85%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

25%

89%

ABBV Street Opinion

ABBV Street view is extremely bullish and have positive views on the near-term outlook

ABBV Risk Level

ABBV has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

LOW

HIGH

ABBV Performance Sentiment

Sentiments overview associated with ABBV events and the stock performance.

85%

10%

Positive

Negative

44 out of 52
events present

5 out of 52
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$229.57

Resistance
Price

$214.05

Current Price Range

$244.38

Show methods +

ABBV Latest Analysis

AbbVie: Strong Buy On Rinvoq Expansions And Immunology Pipeline Addition.

Fri Oct 17, 2025

$229.57 | +1.19%

Rating

AbbVie finishes acquisition of depression asset bretisilocin from Gilgamesh.

Fri Oct 17, 2025

$229.57 | +1.19%

Activity

Cantor Fitzgerald Reaffirms Overweight Rating on AbbVie (ABBV). AbbVie Inc. (NYSE:ABBV) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. A global pharmaceutical company AbbVie Inc. (NYSE:ABBV) is among the best dividend stocks in the healthcare sector. On October 14 C‍antor Fitzgerald reaffirmed⁠ its Overwe⁠ight rating a⁠nd $2‍5⁠0 price targ⁠et‌ f‍or AbbVie Inc. (NYSE:ABBV) while revising its earnings model⁠ to [….]

Thu Oct 16, 2025

$226.87 | +0.21%

Rating

AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know. The latest trading day saw AbbVie (ABBV) settling at $226.22 representing a -1.27% change from its previous close.

Wed Oct 15, 2025

$226.22 | -0.56%

Momentum

Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie?. ABBV leans on booming Skyrizi and Rinvoq-driven sales to sustain growth and counter Humiras decline as Q3 results approach.

Tue Oct 14, 2025

$229.13 | -0.51%

Earnings

AbbVie Gets FDA Approval To Expand RINVOQ Use For Ulcerative Colitis And Crohns Disease . (RTTNews) - AbbVie (ABBV) Monday announced the United States Food and Drug Administration (FDA) approval of a supplemental new drug application (sNDA) that updates the indication statement for RINVOQ (upadacitinib) for the treatment of adults with moderately to severely active ulcerative

Mon Oct 13, 2025

$230.30 | -0.13%

Activity

Ex-Dividend Reminder: Abbott Laboratories AbbVie and ARMOUR Residential REIT . Looking at the universe of stocks we cover at Dividend Channel on 10/15/25 Abbott Laboratories (Symbol: ABT) AbbVie Inc (Symbol: ABBV) and ARMOUR Residential REIT Inc. (Symbol: ARR) will all trade ex-dividend for their respective upcoming dividends. Abbott Laboratories will

Mon Oct 13, 2025

$230.30 | -0.13%

Activity

AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors. New data from telisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic colorectal and solid tumors highlight progress in AbbVies growing ADC portfolio designed to target difficult-to-treat cancers. NORTH CHICAGO Ill. Oct. 13 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today...

Mon Oct 13, 2025

$230.30 | -0.13%

Activity

Carolina Wealth Trims Its AbbVie Stake to Nearly Nothing. Key PointsCarolina Wealth Advisors sold 38267 AbbVie shares. estimated transaction value ~$7.79 million based on quarterly average price

Thu Oct 9, 2025

$230.69 | -0.24%

Activity

Cantor Fitzgerald raises Abbvie stock price target to $250 on strong Skyrizi performance.

Thu Oct 9, 2025

$230.69 | -0.24%

Earnings

Potential

Discover ABBV Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABBV. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ABBV Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ABBV Stock trends

ABBV Stock performance

ABBV Stock analysis

ABBV investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABBV

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABBV

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

ABBV Stock Analysis & IQ Rating | AbbVie

ABBV Stock IQ

ABBV Target Price

ABBV Risk Level

ABBV Analysts Opinion

ABBV Street Consensus

ABBV Performance Sentiment

Technical Price Levels

Explore our ABBV Stock insights

Receive our ABBV Daily Alerts

ABBV Stock IQ

ABBV Street Consensus

ABBV Risk Level

Technical Price Levels

Discover ABBV Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABBV. We're here to help you make informed investment decisions today.

Receive our ABBV Daily Alerts

ABBV Runner Alarm